3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Leukemia, Biphenotypic, Acute
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myeloid, Acute
3
Leukemia, Myeloid, Accelerated Phase
3
Blast Crisis
3
Lymphoma, Mantle-Cell
2
Down Syndrome
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Renal Pelvis and Ureter Urothelial Carcinoma
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Mouth Neoplasms
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Carcinoma
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
pirtobrutinib
3
Cyclophosphamide
3
Azacitidine
3
ibrutinib
2
fludarabine
2
Mycophenolic Acid
2
Lenalidomide
2
zanubrutinib
1
venetoclax
1
ruxolitinib
1
ponatinib
1
nilotinib
1
idelalisib
1
idecabtagene vicleucel
1
fludarabine phosphate
1
cedazuridine
1
cc-486
1
asciminib
1
acalabrutinib
1
Whole-Body Irradiation
1
Vancomycin
1
Tretinoin
1
Tacrolimus
1
Sirolimus
1
Semen Analysis
1
Rituximab
1
Quality of Life
1
Physical Examination
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hematologic Diseases
×
merphos
×
90 days
×
Clear all
No trials found.